Sorry, you need to enable JavaScript to visit this website.
Home Science Research Sites

Each of our R&D centers specializes in a different area of scientific exploration. We have several major campuses located throughout the U.S. and U.K.

AndoverAndover, Massachusetts
A 70-acre site that combines state-of-the-art R&D facilities with flexible, multi-product manufacturing capabilities
boulderBoulder, Colorado
An expert in small molecule drug discovery with a focus on developing innovative cancer therapeutics
CambridgeCambridge, Massachusetts
Global headquarters for our Center for Therapeutic Innovation (CTI), which has established locations in New York City, San Diego, and San Francisco
GrotonGroton, Connecticut
Where nearly every one of our products are, in part, developed
lajollaLa Jolla, California
Powerfully reinforcing the company's presence in the global biotechnology industry
Pearl RiverPearl River, New York
The primary location for our company’s global Vaccine Research and Development work
Sandwich, UKSandwich, UK
Home of the Pharmaceutical Sciences and Global Regulatory Affairs groups
St. Louis, MOSt. Louis, MO
A 300,000 sq. ft. facility producing innovative emergency care products that serve unique needs during severe medical crises
  • 00Phase 1
  • 00Phase 2
  • 00Phase 3
  • 00Registration
  • 00Total

Learn more about the process of joining a clinical trial and find a trial near you.

Go to Pfizer Clinical Trials Site
Science & Innovation

Green Chemistry: A More Sustainable Approach to Medicine Development

Pharmaceutical companies work to ensure that drug development has as little environmental impact as possible with green chemistry principles.
Close-Up of green liquid pouring from pipette in test tubes
Purpose & Ideals

Equity in Advanced Prostate Cancer Care Begins with Changing the Conversation

Talking openly about prostate health is one of the first steps in addressing global health inequities that impact those diagnosed with prostate cancer.
Equity in Advanced Prostate Cancer Care Begins with Changing the Conversation
Programs & Initiatives

Operation Eradication: The Global Health Community Comes Together to Defeat Meningitis by 2030

A new global roadmap to defeat meningitis aims to reduce cases of vaccine-preventable meningitis by 50% and decrease the number of deaths by 70% by 2030.
Operation Eradication: The Global Health Community Comes Together to Defeat Meningitis by 2030